Your browser doesn't support javascript.
loading
Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment.
Gao, Peng; Tang, Kangning; Hao, Yuqiu; Li, Wei; Lv, Xuejiao; Li, Dapeng; Jia, Yuxi.
Afiliação
  • Gao P; Department of Respiratory and Critical Care Medicine, Second Hospital of Jilin University, Changchun, China.
  • Tang K; Department of Respiratory and Critical Care Medicine, Second Hospital of Jilin University, Changchun, China.
  • Hao Y; Department of Respiratory and Critical Care Medicine, Second Hospital of Jilin University, Changchun, China.
  • Li W; Department of Respiratory and Critical Care Medicine, Second Hospital of Jilin University, Changchun, China.
  • Lv X; Department of Respiratory and Critical Care Medicine, Second Hospital of Jilin University, Changchun, China.
  • Li D; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Jilin Medical College, Jilin, China.
  • Jia Y; Department of Orthopedics Application Demonstration Center of Precision Medicine Molecular Diagnosis, the Second Hospital of Jilin University, Changchun, China.
Front Oncol ; 12: 762338, 2022.
Article em En | MEDLINE | ID: mdl-35280798
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article